カテゴリー： QYResearch, 世界

世界の注意欠陥多動性障害(ADHD)薬市場 2019年

【英語タイトル】Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X03802）・商品コード：DATA909X03802
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：108
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、注意欠陥多動性障害(ADHD)薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、興奮剤、非興奮剤に、用途別には、小児、青年、成人にセグメント区分し、注意欠陥多動性障害(ADHD)薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・注意欠陥多動性障害(ADHD)薬の世界市場概要
・注意欠陥多動性障害(ADHD)薬の製造コスト構成分析
・注意欠陥多動性障害(ADHD)薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・注意欠陥多動性障害(ADHD)薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・注意欠陥多動性障害(ADHD)薬のセグメント分析（種類別）
（興奮剤、非興奮剤）
・注意欠陥多動性障害(ADHD)薬のセグメント分析（用途別）
（小児、青年、成人）
・注意欠陥多動性障害(ADHD)薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Eli Lilly、Perdue Pharma、Johnson & Johnson、Janssen Pharmaceuticals, Inc.、Shire、Glaxosmith Kline、Novartis、Celltech Group、）
・注意欠陥多動性障害(ADHD)薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Attention Deficit Hyperactivity Disorder (ADHD) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Attention Deficit Hyperactivity Disorder (ADHD) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Attention Deficit Hyperactivity Disorder (ADHD) Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Attention Deficit Hyperactivity Disorder (ADHD) Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Attention Deficit Hyperactivity Disorder (ADHD) Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Eli Lilly
Perdue Pharma
Johnson & Johnson
Janssen Pharmaceuticals, Inc.
Shire
Glaxosmith Kline
Novartis
Celltech Group

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Stimulants
Non-Stimulants

Segment by Application
Pediatric
Adolescent
Adults

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Attention Deficit Hyperactivity Disorder (ADHD) Drug
1.1 Definition of Attention Deficit Hyperactivity Disorder (ADHD) Drug
1.2 Attention Deficit Hyperactivity Disorder (ADHD) Drug Segment by Type
1.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Stimulants
1.2.3 Non-Stimulants
1.3 Attention Deficit Hyperactivity Disorder (ADHD) Drug Segment by Applications
1.3.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Pediatric
1.3.3 Adolescent
1.3.4 Adults
1.4 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Overall Market
1.4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue (2014-2025)
1.4.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Production (2014-2025)
1.4.3 North America Attention Deficit Hyperactivity Disorder (ADHD) Drug Status and Prospect (2014-2025)
1.4.4 Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Status and Prospect (2014-2025)
1.4.5 China Attention Deficit Hyperactivity Disorder (ADHD) Drug Status and Prospect (2014-2025)
1.4.6 Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Status and Prospect (2014-2025)
1.4.8 India Attention Deficit Hyperactivity Disorder (ADHD) Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Attention Deficit Hyperactivity Disorder (ADHD) Drug
2.3 Manufacturing Process Analysis of Attention Deficit Hyperactivity Disorder (ADHD) Drug
2.4 Industry Chain Structure of Attention Deficit Hyperactivity Disorder (ADHD) Drug

3 Development and Manufacturing Plants Analysis of Attention Deficit Hyperactivity Disorder (ADHD) Drug
3.1 Capacity and Commercial Production Date
3.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Attention Deficit Hyperactivity Disorder (ADHD) Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Attention Deficit Hyperactivity Disorder (ADHD) Drug Production and Capacity Analysis
4.2 Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Analysis
4.3 Attention Deficit Hyperactivity Disorder (ADHD) Drug Price Analysis
4.4 Market Concentration Degree

5 Attention Deficit Hyperactivity Disorder (ADHD) Drug Regional Market Analysis
5.1 Attention Deficit Hyperactivity Disorder (ADHD) Drug Production by Regions
5.1.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Production by Regions
5.1.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue by Regions
5.2 Attention Deficit Hyperactivity Disorder (ADHD) Drug Consumption by Regions
5.3 North America Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Analysis
5.3.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Drug Production
5.3.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Attention Deficit Hyperactivity Disorder (ADHD) Drug Import and Export
5.4 Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Analysis
5.4.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Production
5.4.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Import and Export
5.5 China Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Analysis
5.5.1 China Attention Deficit Hyperactivity Disorder (ADHD) Drug Production
5.5.2 China Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Attention Deficit Hyperactivity Disorder (ADHD) Drug Import and Export
5.6 Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Analysis
5.6.1 Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Production
5.6.2 Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Import and Export
5.7 Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Analysis
5.7.1 Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Production
5.7.2 Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Import and Export
5.8 India Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Analysis
5.8.1 India Attention Deficit Hyperactivity Disorder (ADHD) Drug Production
5.8.2 India Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Attention Deficit Hyperactivity Disorder (ADHD) Drug Import and Export

6 Attention Deficit Hyperactivity Disorder (ADHD) Drug Segment Market Analysis (by Type)
6.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Production by Type
6.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue by Type
6.3 Attention Deficit Hyperactivity Disorder (ADHD) Drug Price by Type

7 Attention Deficit Hyperactivity Disorder (ADHD) Drug Segment Market Analysis (by Application)
7.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Consumption by Application
7.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Consumption Market Share by Application (2014-2019)

8 Attention Deficit Hyperactivity Disorder (ADHD) Drug Major Manufacturers Analysis
8.1 Eli Lilly
8.1.1 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Sites and Area Served
8.1.2 Eli Lilly Product Introduction, Application and Specification
8.1.3 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Perdue Pharma
8.2.1 Perdue Pharma Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Sites and Area Served
8.2.2 Perdue Pharma Product Introduction, Application and Specification
8.2.3 Perdue Pharma Attention Deficit Hyperactivity Disorder (ADHD) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Johnson & Johnson
8.3.1 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Sites and Area Served
8.3.2 Johnson & Johnson Product Introduction, Application and Specification
8.3.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Janssen Pharmaceuticals, Inc.
8.4.1 Janssen Pharmaceuticals, Inc. Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Sites and Area Served
8.4.2 Janssen Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.4.3 Janssen Pharmaceuticals, Inc. Attention Deficit Hyperactivity Disorder (ADHD) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Shire
8.5.1 Shire Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Sites and Area Served
8.5.2 Shire Product Introduction, Application and Specification
8.5.3 Shire Attention Deficit Hyperactivity Disorder (ADHD) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Glaxosmith Kline
8.6.1 Glaxosmith Kline Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Sites and Area Served
8.6.2 Glaxosmith Kline Product Introduction, Application and Specification
8.6.3 Glaxosmith Kline Attention Deficit Hyperactivity Disorder (ADHD) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Novartis
8.7.1 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Sites and Area Served
8.7.2 Novartis Product Introduction, Application and Specification
8.7.3 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Celltech Group
8.8.1 Celltech Group Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Sites and Area Served
8.8.2 Celltech Group Product Introduction, Application and Specification
8.8.3 Celltech Group Attention Deficit Hyperactivity Disorder (ADHD) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served

9 Development Trend of Analysis of Attention Deficit Hyperactivity Disorder (ADHD) Drug Market
9.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Trend Analysis
9.1.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Attention Deficit Hyperactivity Disorder (ADHD) Drug Regional Market Trend
9.2.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Drug Forecast 2019-2025
9.2.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Forecast 2019-2025
9.2.3 China Attention Deficit Hyperactivity Disorder (ADHD) Drug Forecast 2019-2025
9.2.4 Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Forecast 2019-2025
9.2.5 Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Forecast 2019-2025
9.2.6 India Attention Deficit Hyperactivity Disorder (ADHD) Drug Forecast 2019-2025
9.3 Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Trend (Product Type)
9.4 Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Attention Deficit Hyperactivity Disorder (ADHD) Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Attention Deficit Hyperactivity Disorder (ADHD) Drug
Table Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Market Share by Types in 2018
Figure Stimulants Product Picture
Figure Non-Stimulants Product Picture
Table Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Consumption Market Share by Applications in 2018
Figure Pediatric
Figure Adolescent
Figure Adults
Figure Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue (Million USD) (2014-2025)
Figure Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Production (K Pcs) (2014-2025)
Figure North America Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Size (Million USD) (2014-2025)
Figure Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Size (Million USD) (2014-2025)
Figure China Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Size (Million USD) (2014-2025)
Figure Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Size (Million USD) (2014-2025)
Figure India Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Size (Million USD) (2014-2025)
Table Attention Deficit Hyperactivity Disorder (ADHD) Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Attention Deficit Hyperactivity Disorder (ADHD) Drug in 2018
Figure Manufacturing Process Analysis of Attention Deficit Hyperactivity Disorder (ADHD) Drug
Figure Industry Chain Structure of Attention Deficit Hyperactivity Disorder (ADHD) Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Manufacturing Plants Distribution
Table Attention Deficit Hyperactivity Disorder (ADHD) Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Attention Deficit Hyperactivity Disorder (ADHD) Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Attention Deficit Hyperactivity Disorder (ADHD) Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Share by Manufacturers in 2018
Table Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Share by Manufacturers in 2018
Table Attention Deficit Hyperactivity Disorder (ADHD) Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Production by Regions 2014-2019 (K Pcs)
Table Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Market Share by Regions 2014-2019
Figure Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Market Share by Regions in 2018
Table Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Market Share by Regions 2014-2019
Figure Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Market Share by Regions in 2018
Table Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Consumption Market Share by Regions 2014-2019
Figure North America Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Attention Deficit Hyperactivity Disorder (ADHD) Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Production, Consumption Import and Export (K Pcs)
Figure China Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Attention Deficit Hyperactivity Disorder (ADHD) Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Production, Consumption Import and Export (K Pcs)
Figure India Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Attention Deficit Hyperactivity Disorder (ADHD) Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Share by Application (2014-2019)
Table Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Sites and Area Served
Table Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Drug Product Introduction, Application and Specification
Table Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Growth Rate (2014-2019)
Table Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Market Share (2014-2019)
Figure Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Market Share (2014-2019)
Table Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Drug Main Business and Markets Served
Table Perdue Pharma Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Sites and Area Served
Table Perdue Pharma Attention Deficit Hyperactivity Disorder (ADHD) Drug Product Introduction, Application and Specification
Table Perdue Pharma Attention Deficit Hyperactivity Disorder (ADHD) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Perdue Pharma Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Growth Rate (2014-2019)
Table Perdue Pharma Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Market Share (2014-2019)
Figure Perdue Pharma Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Market Share (2014-2019)
Table Perdue Pharma Attention Deficit Hyperactivity Disorder (ADHD) Drug Main Business and Markets Served
Table Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Sites and Area Served
Table Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Drug Product Introduction, Application and Specification
Table Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Growth Rate (2014-2019)
Table Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Market Share (2014-2019)
Figure Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Market Share (2014-2019)
Table Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Drug Main Business and Markets Served
Table Janssen Pharmaceuticals, Inc. Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Sites and Area Served
Table Janssen Pharmaceuticals, Inc. Attention Deficit Hyperactivity Disorder (ADHD) Drug Product Introduction, Application and Specification
Table Janssen Pharmaceuticals, Inc. Attention Deficit Hyperactivity Disorder (ADHD) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Janssen Pharmaceuticals, Inc. Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Growth Rate (2014-2019)
Table Janssen Pharmaceuticals, Inc. Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Market Share (2014-2019)
Figure Janssen Pharmaceuticals, Inc. Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Market Share (2014-2019)
Table Janssen Pharmaceuticals, Inc. Attention Deficit Hyperactivity Disorder (ADHD) Drug Main Business and Markets Served
Table Shire Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Sites and Area Served
Table Shire Attention Deficit Hyperactivity Disorder (ADHD) Drug Product Introduction, Application and Specification
Table Shire Attention Deficit Hyperactivity Disorder (ADHD) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Shire Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Growth Rate (2014-2019)
Table Shire Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Market Share (2014-2019)
Figure Shire Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Market Share (2014-2019)
Table Shire Attention Deficit Hyperactivity Disorder (ADHD) Drug Main Business and Markets Served
Table Glaxosmith Kline Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Sites and Area Served
Table Glaxosmith Kline Attention Deficit Hyperactivity Disorder (ADHD) Drug Product Introduction, Application and Specification
Table Glaxosmith Kline Attention Deficit Hyperactivity Disorder (ADHD) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Glaxosmith Kline Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Growth Rate (2014-2019)
Table Glaxosmith Kline Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Market Share (2014-2019)
Figure Glaxosmith Kline Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Market Share (2014-2019)
Table Glaxosmith Kline Attention Deficit Hyperactivity Disorder (ADHD) Drug Main Business and Markets Served
Table Novartis Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Sites and Area Served
Table Novartis Attention Deficit Hyperactivity Disorder (ADHD) Drug Product Introduction, Application and Specification
Table Novartis Attention Deficit Hyperactivity Disorder (ADHD) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Growth Rate (2014-2019)
Table Novartis Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Market Share (2014-2019)
Figure Novartis Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Market Share (2014-2019)
Table Novartis Attention Deficit Hyperactivity Disorder (ADHD) Drug Main Business and Markets Served
Table Celltech Group Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Sites and Area Served
Table Celltech Group Attention Deficit Hyperactivity Disorder (ADHD) Drug Product Introduction, Application and Specification
Table Celltech Group Attention Deficit Hyperactivity Disorder (ADHD) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Celltech Group Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Growth Rate (2014-2019)
Table Celltech Group Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Market Share (2014-2019)
Figure Celltech Group Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Market Share (2014-2019)
Table Celltech Group Attention Deficit Hyperactivity Disorder (ADHD) Drug Main Business and Markets Served
Figure Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Attention Deficit Hyperactivity Disorder (ADHD) Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Attention Deficit Hyperactivity Disorder (ADHD) Drug by Application (2019-2025)
Table Attention Deficit Hyperactivity Disorder (ADHD) Drug Distributors List
Table Attention Deficit Hyperactivity Disorder (ADHD) Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Eli Lilly、Perdue Pharma、Johnson & Johnson、Janssen Pharmaceuticals, Inc.、Shire、Glaxosmith Kline、Novartis、Celltech Group、

★調査レポート[世界の注意欠陥多動性障害(ADHD)薬市場 2019年] (コード：DATA909X03802)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の注意欠陥多動性障害(ADHD)薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のGABA受容体作動薬市場 2019年
    DATA909X08276 / QYResearch / 2019年11月15日 / ※本調査レポートは、GABA受容体作動薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、バマルゾール、フェニブト、バクロフェン、ガボキサドール、クロノピン（クロナゼパム）、ティアグビンに、用途別には、注意欠陥多動性障害（ADHD）、精神障害及びうつ病、アルツハイマー病、癲癇及び発作、不安及び睡眠障害、肥満及びアルコール依存症にセグメント区分し、GABA受容体作動薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・GABA受容体作動薬の世界市場概要 ・GABA受容体作動薬の製造コスト構成分析 ・GABA受容体作動薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・GABA受容体作動薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・GABA受容体作動薬のセグメント分析（種類別） （バマルゾール、フェニブト、バクロフェン、ガボキサドール、クロノピン（クロナゼパム）、ティアグビン）...The global GABA Receptor Agonist Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on GABA Receptor Agonist Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall GABA Receptor Agonist Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of GABA Receptor Agonist Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の胃腸運動障害薬市場 2019年
    DATA909X08373 / QYResearch / 2019年11月15日 / ※本調査レポートは、胃腸運動障害薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ベルセトラグ、イパモレリン、TD-8954、その他に、用途別には、病院、診療所、家庭用にセグメント区分し、胃腸運動障害薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・胃腸運動障害薬の世界市場概要 ・胃腸運動障害薬の製造コスト構成分析 ・胃腸運動障害薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・胃腸運動障害薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・胃腸運動障害薬のセグメント分析（種類別） （ベルセトラグ、イパモレリン、TD-8954、その他）...The global Gastric Motility Disorder Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Gastric Motility Disorder Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Gastric Motility Disorder Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Gastric Motility Disorder Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の甲状腺ホルモン障害薬市場 2019年
    DATA909X16560 / QYResearch / 2019年11月22日 / ※本調査レポートは、甲状腺ホルモン障害薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、注射剤、経口剤、その他に、用途別には、病院、クリニック、医療センター、その他にセグメント区分し、甲状腺ホルモン障害薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・甲状腺ホルモン障害薬の世界市場概要 ・甲状腺ホルモン障害薬の製造コスト構成分析 ・甲状腺ホルモン障害薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・甲状腺ホルモン障害薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・甲状腺ホルモン障害薬のセグメント分析（種類別） （注射剤、経口剤、その他）...The global Thyroid Hormone Disorder Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Thyroid Hormone Disorder Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Thyroid Hormone Disorder Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Thyroid Hormone Disorder Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界のADHD薬市場 2019年
    DATA909X02967 / QYResearch / 2019年11月15日 / ※本調査レポートは、ADHD薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、興奮剤(アンフェタミン、メチルフェニデート)、非興奮剤、抗うつ薬、血圧薬に、用途別には、大人、子供にセグメント区分し、ADHD薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ADHD薬の世界市場概要 ・ADHD薬の製造コスト構成分析 ・ADHD薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ADHD薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ADHD薬のセグメント分析（種類別） （興奮剤(アンフェタミン、メチルフェニデート)、非興奮剤、抗うつ薬、血圧薬）...The global ADHD Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on ADHD Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall ADHD Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of ADHD Drugs in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their ADHD Drugs manufacturing...
  • 世界の女性用性的欲求低下障害治療市場 2019年
    DATA909X07650 / QYResearch / 2019年11月15日 / ※本調査レポートは、女性用性的欲求低下障害治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BP-101、ブレメラノチド、ゲピロン塩酸塩ER、PVT-011、その他に、用途別には、外来患者、入院患者にセグメント区分し、女性用性的欲求低下障害治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・女性用性的欲求低下障害治療の世界市場概要 ・女性用性的欲求低下障害治療の製造コスト構成分析 ・女性用性的欲求低下障害治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・女性用性的欲求低下障害治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・女性用性的欲求低下障害治療のセグメント分析（種類別） （BP-101、ブレメラノチド、ゲピロン塩酸塩ER、PVT-011、その他）...The global Female Hypoactive Sexual Desire Disorder Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Female Hypoactive Sexual Desire Disorder Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Female Hypoactive Sexual Desire Disorder Therapeutics market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Female Hypoactive Sexual Desire Disorder Therapeutics in North America, Europe, China,...
  • 世界の強迫性障害治療市場 2019年
    DATA909X12150 / QYResearch / 2019年11月20日 / ※本調査レポートは、強迫性障害治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ADX-88178、ビトペルチン、CR-5542、分散剤IR、マレイン酸フルボキサミン、マヴォグルラント、その他に、用途別には、クリニック、病院、研究センターにセグメント区分し、強迫性障害治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・強迫性障害治療の世界市場概要 ・強迫性障害治療の製造コスト構成分析 ・強迫性障害治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・強迫性障害治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・強迫性障害治療のセグメント分析（種類別） （ADX-88178、ビトペルチン、CR-5542、分散剤IR、マレイン酸フルボキサミン、マヴォグルラント、その他）...The global Obsessive-Compulsive Disorder Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Obsessive-Compulsive Disorder Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Obsessive-Compulsive Disorder Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Obsessive-Compulsive Disorder Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆